408 related articles for article (PubMed ID: 24782859)
21. Immune Response to Dengue and Zika.
Ngono AE; Shresta S
Annu Rev Immunol; 2018 Apr; 36():279-308. PubMed ID: 29345964
[TBL] [Abstract][Full Text] [Related]
22. Development of a transmission model for dengue virus.
Christofferson RC; McCracken MK; Johnson AM; Chisenhall DM; Mores CN
Virol J; 2013 Apr; 10():127. PubMed ID: 23617898
[TBL] [Abstract][Full Text] [Related]
23. The immunogenicity of tetravalent dengue DNA vaccine in mice pre-exposed to Japanese encephalitis or Dengue virus antigens.
Prompetchara E; Ketloy C; Keelapang P; Sittisombut N; Ruxrungtham K
Asian Pac J Allergy Immunol; 2015 Sep; 33(3):182-8. PubMed ID: 26342114
[TBL] [Abstract][Full Text] [Related]
24. Immune Responses to Dengue and Zika Viruses-Guidance for T Cell Vaccine Development.
Roth C; Delgado FG; Simon-Lorière E; Sakuntabhai A
Int J Environ Res Public Health; 2018 Feb; 15(2):. PubMed ID: 29473899
[TBL] [Abstract][Full Text] [Related]
25. A lethal model of disseminated dengue virus type 1 infection in AG129 mice.
Milligan GN; Sarathy VV; White MM; Greenberg MB; Campbell GA; Pyles RB; Barrett ADT; Bourne N
J Gen Virol; 2017 Oct; 98(10):2507-2519. PubMed ID: 28949904
[TBL] [Abstract][Full Text] [Related]
26. The Role of Heterotypic DENV-specific CD8
Talarico LB; Batalle JP; Byrne AB; Brahamian JM; Ferretti A; García AG; Mauri A; Simonetto C; Hijano DR; Lawrence A; Acosta PL; Caballero MT; Paredes Rojas Y; Ibañez LI; Melendi GA; Rey FA; Damonte EB; Harris E; Polack FP
EBioMedicine; 2017 Jun; 20():202-216. PubMed ID: 28483582
[TBL] [Abstract][Full Text] [Related]
27. Influence of antibodies and T cells on dengue disease outcome: insights from interferon receptor-deficient mouse models.
Tang WW; Grewal R; Shresta S
Curr Opin Virol; 2015 Aug; 13():61-6. PubMed ID: 26001278
[TBL] [Abstract][Full Text] [Related]
28. Protection from secondary dengue virus infection in a mouse model reveals the role of serotype cross-reactive B and T cells.
Zompi S; Santich BH; Beatty PR; Harris E
J Immunol; 2012 Jan; 188(1):404-16. PubMed ID: 22131327
[TBL] [Abstract][Full Text] [Related]
29. Complexity of Neutralizing Antibodies against Multiple Dengue Virus Serotypes after Heterotypic Immunization and Secondary Infection Revealed by In-Depth Analysis of Cross-Reactive Antibodies.
Tsai WY; Durbin A; Tsai JJ; Hsieh SC; Whitehead S; Wang WK
J Virol; 2015 Jul; 89(14):7348-62. PubMed ID: 25972550
[TBL] [Abstract][Full Text] [Related]
30. Dengue Virus Infection with Highly Neutralizing Levels of Cross-Reactive Antibodies Causes Acute Lethal Small Intestinal Pathology without a High Level of Viremia in Mice.
Watanabe S; Chan KW; Wang J; Rivino L; Lok SM; Vasudevan SG
J Virol; 2015 Jun; 89(11):5847-61. PubMed ID: 25787279
[TBL] [Abstract][Full Text] [Related]
31. Dengue encephalitis-associated immunopathology in the mouse model: Implications for vaccine developers and antigens inducer of cellular immune response.
Marcos E; Lazo L; Gil L; Izquierdo A; Suzarte E; Valdés I; Blanco A; Ancizar J; Alba JS; Pérez Yde L; Cobas K; Romero Y; Guillén G; Guzmán MG; Hermida L
Immunol Lett; 2016 Aug; 176():51-6. PubMed ID: 27233365
[TBL] [Abstract][Full Text] [Related]
32. Characterization of a murine model of non-lethal, symptomatic dengue virus infection.
Sarathy VV; White M; Li L; Kaiser JA; Campbell GA; Milligan GN; Bourne N; Barrett ADT
Sci Rep; 2018 Mar; 8(1):4900. PubMed ID: 29559699
[TBL] [Abstract][Full Text] [Related]
33. Aspects of T Cell-Mediated Immunity Induced in Mice by a DNA Vaccine Based on the Dengue-NS1 Antigen after Challenge by the Intracerebral Route.
Oliveira ER; Gonçalves AJ; Costa SM; Azevedo AS; Mantuano-Barradas M; Nogueira AC; Alves AM
PLoS One; 2016; 11(9):e0163240. PubMed ID: 27631083
[TBL] [Abstract][Full Text] [Related]
34. A Dengue Virus Type 4 Model of Disseminated Lethal Infection in AG129 Mice.
Milligan GN; Sarathy VV; Infante E; Li L; Campbell GA; Beatty PR; Harris E; Barrett AD; Bourne N
PLoS One; 2015; 10(5):e0125476. PubMed ID: 25938762
[TBL] [Abstract][Full Text] [Related]
35. CD8+ T Cells Can Mediate Short-Term Protection against Heterotypic Dengue Virus Reinfection in Mice.
Zellweger RM; Tang WW; Eddy WE; King K; Sanchez MC; Shresta S
J Virol; 2015 Jun; 89(12):6494-505. PubMed ID: 25855749
[TBL] [Abstract][Full Text] [Related]
36. A tetravalent virus-like particle vaccine designed to display domain III of dengue envelope proteins induces multi-serotype neutralizing antibodies in mice and macaques which confer protection against antibody dependent enhancement in AG129 mice.
Ramasamy V; Arora U; Shukla R; Poddar A; Shanmugam RK; White LJ; Mattocks MM; Raut R; Perween A; Tyagi P; de Silva AM; Bhaumik SK; Kaja MK; Villinger F; Ahmed R; Johnston RE; Swaminathan S; Khanna N
PLoS Negl Trop Dis; 2018 Jan; 12(1):e0006191. PubMed ID: 29309412
[TBL] [Abstract][Full Text] [Related]
37. Phenotypic characterization of patient dengue virus isolates in BALB/c mice differentiates dengue fever and dengue hemorrhagic fever from dengue shock syndrome.
Tuiskunen A; Wahlström M; Bergström J; Buchy P; Leparc-Goffart I; Lundkvist A
Virol J; 2011 Aug; 8():398. PubMed ID: 21835036
[TBL] [Abstract][Full Text] [Related]
38. Dengue virus infection: current concepts in immune mechanisms and lessons from murine models.
Guabiraba R; Ryffel B
Immunology; 2014 Feb; 141(2):143-56. PubMed ID: 24182427
[TBL] [Abstract][Full Text] [Related]
39. Mapping the Human Memory B Cell and Serum Neutralizing Antibody Responses to Dengue Virus Serotype 4 Infection and Vaccination.
Nivarthi UK; Kose N; Sapparapu G; Widman D; Gallichotte E; Pfaff JM; Doranz BJ; Weiskopf D; Sette A; Durbin AP; Whitehead SS; Baric R; Crowe JE; de Silva AM
J Virol; 2017 Mar; 91(5):. PubMed ID: 28031369
[TBL] [Abstract][Full Text] [Related]
40. Complement-mediated neutralization of dengue virus requires mannose-binding lectin.
Avirutnan P; Hauhart RE; Marovich MA; Garred P; Atkinson JP; Diamond MS
mBio; 2011; 2(6):. PubMed ID: 22167226
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
